India covid-19 experts 2020 patient India

Indian demand for covid-19 drug remdesivir rising sharply: Cipla

Reading now: 973
www.livemint.com

BENGALURU : Demand for COVID-19 antiviral drug remdesivir is rising sharply in India, a top executive at drugmaker Cipla Ltd said on Monday, even as experts remain divided over its effectiveness.Remdesivir was developed by U.S.

drugmaker Gilead Sciences Inc , which cut its 2020 revenue forecast last month, citing lower-than-expected demand and difficulty in predicting sales of the treatment.

Cipla is among several firms licensed to make and sell generic versions in developing nations. Cipla's version, Cipremi, was commercially launched in July and costs just above $50 per 100 mg vial."From October onwards, (the company is) seeing very sharp increase in (remdesivir) monthly volumes ...

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA